Summary & Overview
CPT 82375: Carboxyhemoglobin Measurement
CPT code 82375 designates a laboratory measurement of carboxyhemoglobin, the hemoglobin–carbon monoxide complex used to detect and quantify carbon monoxide exposure. The test is clinically important for diagnosing acute and chronic carbon monoxide poisoning, guiding acute care decisions in emergency and inpatient settings, and supporting occupational and public health surveillance. Nationally, timely measurement of carboxyhemoglobin informs patient triage and hyperbaric oxygen consideration and is a critical component of toxicology testing panels.
Key payers referenced include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and payer relevance for CPT code 82375. The publication covers expected use cases, common billing modifiers (listed separately), and where this test fits within laboratory service lines. It also outlines benchmarking and policy considerations affecting coverage and utilization without prescribing clinical actions.
This summary is intended for health policy analysts, clinical laboratory managers, billing professionals, and payer contracting teams seeking a focused, national-level briefing on CPT code 82375 and its role in carbon monoxide exposure assessment.
Billing Code Overview
CPT code 82375 measures carboxyhemoglobin, the complex formed when carbon monoxide binds to hemoglobin. This laboratory test quantifies the proportion of hemoglobin bound to carbon monoxide and is used to assess exposure to carbon monoxide, a colorless, odorless, and potentially lethal gas produced by combustion of fuels.
Service type: Laboratory diagnostic assay for toxicology exposure assessment
Typical site of service: Clinical laboratory or hospital laboratory (emergency department and inpatient settings for suspected acute exposure)
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to the emergency department or urgent care after suspected carbon monoxide (CO) exposure from smoke inhalation, faulty heating, or vehicle exhaust. The patient may have headache, dizziness, nausea, confusion, syncope, or unexplained hypoxemia. Initial evaluation includes history, pulse oximetry (which may be falsely normal), and triage assessment. A blood sample (venous or arterial) is collected and sent to the laboratory for measurement of carboxyhemoglobin using spectrophotometric or co-oximetry methods. The lab analyst performs 82375 to quantify the percentage of hemoglobin bound to carbon monoxide. Results are returned to the treating clinician to confirm CO exposure, guide supplemental oxygen therapy or hyperbaric oxygen consideration, and document occupational or public health reporting when indicated. Typical sites of service include emergency departments, urgent care centers, inpatient hospital wards, occupational health clinics, and reference laboratories.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician interpretation/report portion if separated from the technical lab component. |
TC |